Executive action is needed to change national guidelines
- John Barnes, Clinical director, medicine,
- Margaret Abban, Consultant, medical admissions unit,
- Paul Howarth, Consultant in accident and emergency
- Royal Cornwall Hospital, Truro, Cornwall TR1 3EB
- Paracetamol Information Centre, Suite 413 Butlers Wharf, London SE1 2ND
- Ear, Nose, and Throat Department, Tyrone County Hospital, Omagh, County Tyrone BT79 0AP
- Accident and Emergency Department, Aberdeen Royal Infirmary, Aberdeen AB25 2ZD
- Wolfson Unit of Clinical Pharmacology, Department of Pharmacological Sciences, University of Newcastle, Newcastle upon Tyne NE2 4HH
- New Cross Hospital, Wolverhampton WV10 0QP
- Gloucestershire Royal Hospital, Gloucester GL1 3NN
- Crisis Recovery Unit, Bethlem and Maudsley NHS Trust, London SE5 8AZ
- Department of Medicine, King's College School of Medicine, London SE5 9PJ
- King's College Hospital, London SE5 9RS
- Accident and Emergency Department, St Mary's Hospital, London W2 1NY
Editorial p 1609
EDITOR—The lesson of the week by Bridger et al on deaths from low dose paracetamol poisoning was most welcome but probably titled incorrectly.1 None of the patients in the cases described took low doses of paracetamol. What did happen was that the current national guidelines for treating patients after poisoning with paracetamol failed to protect these patients.
We suspect that many doctors will have read these cases and dismissed them as poor management, assuming, for example, that the doctors concerned failed to establish the correct timing of the drug ingestion. We fear that complacency will persist with the belief that deaths will not happen if the current guidelines are adhered to properly.
One of the cases was managed in our hospital. The timing and circumstances of the poisoning seemed to be and still do seem to be clear cut. We know the time at which the paracetamol was purchased from a local shop and the time immediately after at which help was sought. These times concur with the history that was given. The concentrations of paracetamol at four hours were 22% below the national standard treatment line. We believe that the nomogram should allow for a safety margin of 22%.
We agree that there are many possible explanations for our patient's death. Our patient may have been particularly susceptible to paracetamol but equally may have taken a sequential overdose. The key point is that a treatment strategy must allow a margin of safety that allows for some degree of inaccuracy in the history or an individual patient's susceptibility to paracetamol.
We are from the hospital in the south west referred to in the article that has changed its treatment protocol to a lower treatment line. Since making this change in 1994 we have treated around an …
Sign in
Personal subscribers, sign in here:
Article access
Article access for 1 day
Purchase this article for £20 $30 €32*
The PDF version can be downloaded as your personal record
CiteULike
Connotea
Del.icio.us
Digg
Facebook
Reddit
Technorati
Twitter
Stumbleupon
Rapid responses
Latest Responses
The decline in the breast cancer incidence is 1.2% and it is not significant.
Published 10 February 2012
'twas ever thus
Published 10 February 2012
The value of historic human remains
Published 10 February 2012
In Praise of British Literature
Published 10 February 2012
Is real shared decision making possible?
Published 10 February 2012
Most responses
Does anyone understand the government’s plan for the NHS? (17 responses)
Published 17 Jan 2012
Bad medicine: medical nutrition (15 responses)
Published 18 Jan 2012
Shared decision making: really putting patients at the centre of healthcare (7 responses)
Published 27 Jan 2012
Why legislation is necessary for my health reforms (7 responses)
Published 1 Feb 2012
Search for evidence goes on (5 responses)
Published 17 Jan 2012